You close your Series A. The wires clear. The team celebrates. And then, almost immediately, a clock starts that nobody told you about.
Your investors expect to see commercial momentum at the 90-day board meeting. That means pipeline, content, market presence — proof that the capital is working. But the 90-day mark is also exactly when most life science companies are still trying to figure out who's writing the LinkedIn posts.
This is the six-month lag. It's the gap between when funding closes and when real commercial activity starts producing results. And it's killing more fundraises than founders realize.
Why the lag happens
It's not laziness. It's structure. Here's what actually happens after a round closes:
The first two to four weeks get absorbed by admin. Wire transfers, updated cap tables, new banking arrangements, board formalities. Nobody's thinking about marketing yet because nobody's paid to think about marketing yet.
Weeks four through eight, the founder starts the hiring process for a head of marketing. Job descriptions go up. Recruiters get briefed. First interviews happen. Meanwhile, nothing ships.
Weeks eight through sixteen, a hire is made. They spend the first 30 to 60 days learning the science, meeting the team, and building a "strategy." Still nothing ships.
By week sixteen — four months in — you have one person who has produced a brand audit and a content calendar. Your 90-day board meeting happened without any meaningful commercial progress to show. Your Series B investors are watching a company that raised $8M and still has no market presence.
"The hiring process alone takes longer than most founders plan for. By the time someone is actually producing work, half your runway to the next milestone is gone."
The cost isn't just time
Speed to commercial traction is a real valuation variable in life science. Investors doing diligence on your Series B aren't just looking at your science — they're looking at evidence that the market wants what you're building. Pipeline conversations. KOL relationships. Conference presence. Content that positions you as a credible commercial actor.
Companies that show up to their Series B with six months of commercial activity look fundamentally different from companies that show up with six months of hiring and strategy decks. The gap in valuation and deal terms isn't small.
And the lag compounds. If you're six months behind at your Series B, you're likely twelve months behind at your Series C. The companies that figure out early-stage commercial infrastructure tend to keep that advantage.
What to do instead
The answer isn't to rush the wrong hire. It's to start commercial activity before the hire exists.
There's a specific window — roughly the 30 days before close and the 60 days after — where outside help can build the infrastructure that would otherwise wait for an internal hire. Content engine, outreach pipeline, brand presence, operational dashboard. By the time a full-time marketing person starts, the machine is already running. Their job becomes managing and growing it, not building it from zero.
That changes what a 90-day board meeting looks like. Instead of "we've started the hiring process," you're showing pipeline conversations, published content, conference registrations, and a commercial cadence that's already in motion.
The question to ask before you close
Most founders ask: "Who are we going to hire?" The better question is: "What needs to be built before we hire, and how fast can we build it?"
The two questions lead to very different first 90 days.
Closing a round in the next 90 days?
This is exactly what the 90-Day Market-Readiness Sprint is built for. Let's talk before you close.